Abstract
The phosphoethanolamine, known as "cancer pill", have aroused interest in the scientific community because of the wide publicity and impact of press reports on the production and distribution of synthetic phosphoethanolamine in cancer treatment by São Carlos Chemistry Institute - University of São Paulo (USP), without the approval of the National Health Surveillance Agency (ANVISA). Even …